Graig Suvannavejh

Stock Analyst at Mizuho

(4.53)
# 266
Out of 5,152 analysts
174
Total ratings
54.55%
Success rate
21.59%
Average return

Stocks Rated by Graig Suvannavejh

Palvella Therapeutics
Feb 25, 2026
Maintains: Outperform
Price Target: $205$250
Current: $135.49
Upside: +84.52%
Insmed
Feb 24, 2026
Maintains: Outperform
Price Target: $211$204
Current: $149.88
Upside: +36.11%
LeonaBio
Feb 19, 2026
Upgrades: Outperform
Price Target: $10
Current: $5.98
Upside: +67.22%
Immix Biopharma
Feb 9, 2026
Initiates: Outperform
Price Target: $14
Current: $8.56
Upside: +63.55%
Erasca
Dec 9, 2025
Maintains: Outperform
Price Target: $4$5
Current: $15.12
Upside: -66.93%
Terns Pharmaceuticals
Dec 9, 2025
Maintains: Outperform
Price Target: $33$54
Current: $42.53
Upside: +26.97%
Belite Bio
Dec 2, 2025
Upgrades: Outperform
Price Target: $105$194
Current: $177.79
Upside: +9.12%
Harmony Biosciences Holdings
Dec 1, 2025
Maintains: Outperform
Price Target: $39$46
Current: $28.54
Upside: +61.18%
Tarsus Pharmaceuticals
Nov 20, 2025
Initiates: Outperform
Price Target: $100
Current: $76.20
Upside: +31.23%
Immatics
Nov 19, 2025
Maintains: Outperform
Price Target: $19$23
Current: $10.18
Upside: +125.93%
Maintains: Neutral
Price Target: $54$56
Current: $70.02
Upside: -20.02%
Maintains: Outperform
Price Target: $44$46
Current: $34.68
Upside: +32.64%
Maintains: Outperform
Price Target: $200$202
Current: $164.08
Upside: +23.11%
Maintains: Neutral
Price Target: $24$19
Current: $19.86
Upside: -4.33%
Maintains: Neutral
Price Target: $2$4
Current: $1.65
Upside: +142.42%
Initiates: Outperform
Price Target: $30
Current: $0.35
Upside: +8,588.10%
Upgrades: Outperform
Price Target: $2.5$3.5
Current: $2.15
Upside: +62.79%
Maintains: Outperform
Price Target: $4$5
Current: $3.05
Upside: +63.93%
Maintains: Outperform
Price Target: $8$10
Current: $5.17
Upside: +93.42%
Maintains: Outperform
Price Target: $12$11
Current: $17.84
Upside: -38.34%
Maintains: Outperform
Price Target: $30$26
Current: $18.00
Upside: +44.44%
Maintains: Outperform
Price Target: $7$8
Current: $15.05
Upside: -46.84%
Maintains: Neutral
Price Target: $38$33
Current: $33.73
Upside: -2.16%
Upgrades: Buy
Price Target: $7$7.6
Current: $1.63
Upside: +366.26%
Reiterates: Outperform
Price Target: $74
Current: $8.42
Upside: +778.86%
Downgrades: Neutral
Price Target: $17$1
Current: $2.81
Upside: -64.41%
Maintains: Buy
Price Target: $31$35
Current: $91.00
Upside: -61.54%
Maintains: Neutral
Price Target: $9$8
Current: $26.84
Upside: -70.19%
Maintains: Buy
Price Target: $71$57
Current: $62.27
Upside: -8.46%
Maintains: Sell
Price Target: $8$5
Current: $29.19
Upside: -82.87%
Initiates: Buy
Price Target: $34
Current: $10.97
Upside: +209.94%
Initiates: Neutral
Price Target: $28
Current: $10.37
Upside: +170.01%
Initiates: Neutral
Price Target: $31
Current: $28.88
Upside: +7.34%
Initiates: Sell
Price Target: $380
Current: $15.05
Upside: +2,424.92%
Initiates: Neutral
Price Target: $4.75
Current: $1.63
Upside: +191.41%
Upgrades: Buy
Price Target: $36
Current: $24.12
Upside: +49.25%
Downgrades: Sell
Price Target: n/a
Current: $33.69
Upside: -
Initiates: Neutral
Price Target: $37
Current: $2.81
Upside: +1,216.73%
Downgrades: Sell
Price Target: $128
Current: $188.69
Upside: -32.16%